Securities Purchase Agreement
(i) Subject to the terms and conditions of this Agreement, each Purchaser, severally and not jointly, agrees to purchase, and the Company agrees to sell to each Purchaser, at the Closing (as defined below), that number of Units (including the Firm Units and Excess Units, each as defined below) set forth opposite such Purchasers name on Schedule A attached hereto. The purchase price of each Unit shall be $2.50 (the Per Unit Price), except in the case of each Unit purchased by a director or officer of the Company which shall be $2.99 (the Insider Per Unit Price) and each shall be payable as hereafter set forth. | |
(ii) Notwithstanding anything to the contrary in this Agreement, on the Closing Date, no more than 6,302,318 Units representing 6,302,318 shares of Common Stock (the Firm Shares) and associated Warrants (the Firm Warrants, and together with the Firm Shares, the Firm Units) shall be issued to the Purchasers prior to the Company obtaining shareholder approval to issue to the Purchasers the shares of Common Stock in excess of the Firm Units in accordance with the requirements of NASDAQ Rule 4350(i) and Section 5(d) hereto (the Shareholder Approval). Prior to obtaining the Shareholder Approval, the Units to be purchased by the Purchasers (including the Warrants thereto) representing Purchased Shares in excess of the Firm Units (the Excess Units) shall not be issued to the Purchasers and instead the proceeds in respect of such Excess Units (the Excess Funds) shall be deposited into |
A-1
escrow, in accordance with the terms of an escrow agreement, substantially in the form of Exhibit D hereto (the Escrow Agreement). The Excess Funds shall accrue interest from and including the day following the Closing Date to and excluding the date of release in accordance with the terms of the Escrow Agreement at a rate of 7.0% per annum (computed on the basis of a 365-day year). If the Company obtains the Shareholder Approval prior to the Shareholder Approval Date (as defined below), the Excess Funds shall be released to the Company in accordance with the Escrow Agreement, and the Excess Units shall be issued to each of the Purchasers in the amounts set forth on Schedule A hereto, along with such Purchasers pro rata share of accrued interest on the Excess Funds to such date, which shall be payable in cash. If the Company does not obtain the Shareholder Approval prior to the Shareholder Approval Date (as defined below), the Excess Funds shall be returned to each of the Purchasers in accordance with the terms of the Escrow Agreement, along with such Purchasers pro rata share of accrued interest on the Excess Funds to such date. If the Excess Funds accrue earnings or interest in escrow at a rate less than the rate required by this Section 1(b)(ii), the Company shall promptly pay to the Purchasers any shortfall amount. |
A-2
(i) The authorized capital stock of the Company consists of 175,000,000 shares of Common Stock, $.01 par value per share, and 10,000,000 shares of preferred stock, par value $1.00 per share (Preferred Stock). | |
(ii) As of June 30, 2005, the issued and outstanding capital stock of the Company consisted of 32,424,929 shares of Common Stock and no shares of Preferred Stock. The shares of issued and outstanding capital stock of the Company have been duly authorized and validly issued, are fully paid and nonassessable and have not been issued in violation of or are not otherwise subject to any preemptive or other similar rights. | |
(iii) As of June 30, 2005, the Company had 10,110,617 shares of Common Stock reserved for issuance upon exercise of options granted under the Companys stock option plans. | |
(iv) As of June 30, 2005, the Company had outstanding options for 8,211,325 shares of Common Stock. | |
(v) As of June 30, 2005, the Company had 3,755,370 issued and outstanding warrants for the purchase of shares of Common Stock. |
A-3
(i) Purchased Shares. The Purchased Shares have been duly authorized and, when issued and delivered to each Purchaser against payment therefor in accordance with the terms of this Agreement, will be validly issued, fully paid and non-assessable and will be free and clear from all liens, claims and encumbrances with respect to the issuance of such Purchased Shares and will not be subject to any pre-emptive rights or similar rights. | |
(ii) Purchased Warrants. The Purchased Warrants to be issued pursuant to this Agreement have been duly authorized and, when issued and delivered to each Purchaser against payment therefor in accordance with the terms of this Agreement, will be validly issued and will be free and clear from all liens, claims and encumbrances with respect to the issuance of such Purchased Warrants and will not be subject to any pre-emptive rights or similar rights. | |
(iii) Warrant Shares. The issuance of the Warrant Shares issued or issuable from time to time upon the exercise of the Purchased Warrants have been, and at all times prior to such exercise, will be, duly authorized and duly reserved for issuance upon such exercise and payment of the exercise price of the Purchased Warrants and, when issued and delivered to each Purchaser upon exercise against payment therefor in accordance with the terms of the Warrant, will be validly issued, fully paid and non-assessable and will be free and clear from all liens, claims and encumbrances with respect to the issuance of such Warrant Shares and will not be subject to any pre-emptive rights or similar rights. |
A-4
(1) Reports. The Company has filed in a timely manner all reports, schedules, forms, statements and other documents required to be filed by it with the Securities and Exchange Commission (the SEC) pursuant to the reporting requirements of the Exchange Act and the rules and regulations promulgated thereunder. The Company has made available to the Purchasers prior to the date hereof copies of its Annual Report on Form 10-K for the fiscal year ended December 31, 2004, as amended (the Form 10-K), its quarterly report on Form 10-Q for the fiscal quarter ended March 31, 2005 (the Form 10-Q), and any Current Report on Form 8-K for events occurring since December 31, 2004 (Form 8-Ks) filed or furnished by the Company with the SEC (the Form 10-K, the Form 10-Q and the Form 8-Ks are collectively referred to herein as the SEC Documents). Each of the SEC Documents, as of the respective dates thereof (or, if amended or superseded by a filing or submission, as the case may be, prior to the Closing Date, then on the date of such filing or submission, as the case may be), (1) did not contain any untrue statement of a material fact nor omit to state a material fact |
A-5
necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading and (2) complied in all material respects with the requirements of the Exchange Act and the rules and regulations of the SEC promulgated thereunder applicable to such SEC Document. | |
(2) Sarbanes-Oxley. The Chief Executive Officer and the Chief Financial Officer of the Company have signed, and the Company has furnished to the SEC, all certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. Such certifications contain no qualifications or exceptions to the matters certified therein (other than such qualifications or exceptions that are permitted under the Exchange Act and the rules promulgated thereunder) and have not been modified or withdrawn; and neither the Company nor any of its officers has received notice from any governmental entity questioning or challenging the accuracy, completeness, form or manner of filing or submission of such certifications. Without limiting the foregoing, the Company is in compliance with any applicable requirements of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated thereunder, as amended, that are currently in effect. | |
(3) Financial Statements. The consolidated financial statements of the Company included in the SEC Documents (1) comply as to form in all material respects with the rules and regulations of the SEC with respect thereto as were in effect at the time of filing and (2) present fairly, in all material respects, in accordance with United States generally accepted accounting principles (GAAP), consistently applied, the consolidated financial position of the Company as of the dates indicated therein, and the consolidated results of its operations and cash flows for the periods therein specified, subject, in the case of unaudited consolidated financial statements for interim periods, to normal, immaterial year-end audit adjustments. |
(i) any declaration, setting aside or payment of any dividend or other distribution of the assets of the Company with respect to any shares of capital stock of the Company or any repurchase, redemption or other acquisition by the Company or any Subsidiary of the Company of any outstanding shares of the Companys capital stock; | |
(ii) any damage, destruction or loss to the Companys or any Subsidiarys business or assets, whether or not covered by insurance, except for such occurrences, individually and collectively, that have not had, and would not reasonably be expected to have, a Material Adverse Effect; | |
(iii) any waiver by the Company or any Subsidiary of a valuable right or of a material debt owed to it, except for such waivers, individually and collectively, that have not had, and would not reasonably be expected to have, a Material Adverse Effect; | |
(iv) any material change or amendment to, or any waiver of any material right under a material contract or arrangement by which the Company, any Subsidiary or any of their assets or properties is bound or subject; | |
(v) any transaction between the Company or any Subsidiary, on the one hand, and any of its officers or directors, on the other hand, that would be required to be disclosed pursuant to Item 404(a), (b) or (c) of Regulation S-K of the SEC; | |
(vi) any change by the Company in its accounting principles, methods or practices or in the manner in which it keeps its accounting books and records, except any such change required by a change in GAAP or by the SEC; or | |
(vii) any other event or condition, either individually or collectively, that has had, or would be reasonably likely to have, a Material Adverse Effect. |
A-6
A-7
A-8
(i) Such Purchaser understands that the Purchased Securities and the Warrant Shares have not been registered under the Securities Act and will not sell, offer to sell, assign, pledge, hypothecate or otherwise transfer any of the Purchased Securities or the Warrant Shares (except as permitted in Section 4(k) below) unless (A) pursuant to an effective registration statement under the Securities Act, (B) such Purchaser provides a reasonably acceptable legal opinion to the Company, to the effect that a sale, assignment, pledge, hypothecation or other transfer of the Purchased Securities or the Warrant Shares, as the case may be, may be made without registration under the Securities Act and the transferee agrees to be bound by the terms and conditions of this Agreement, (C) such Purchaser provides the Company a no action letter from the SEC to the effect that the transfer of the Purchased Securities or the Warrant Shares, as the case may be, without registration will not result in a recommendation by the Staff of the SEC that enforcement action by taken with respect thereto, (D) such Purchaser provides the Company with reasonable assurances (in the form of seller and broker representation letters) that the Purchased Securities or the Warrant Shares, as the case may be, can be sold pursuant to Rule 144 promulgated under the Securities Act (Rule 144), (E) such Purchaser provides the Company with reasonable assurances (in the form of seller representation letters) that the Purchased Securities or the Warrant Shares, as the case may be, can be sold pursuant to Rule 144(k) promulgated under the Securities Act following the applicable holding period or (F) pursuant to any other exception contained in the Securities Act provided that the Purchaser provides a reasonably acceptable legal opinion to the Company. Notwithstanding anything to the contrary contained in this Agreement, including but not limited to in Section 5(c)(i) below, such Purchaser may transfer the Purchased Securities or the Warrant Shares to its Affiliates provided that (X) such Purchaser provides the Company with a reasonably acceptable legal opinion, (Y) such Affiliate is an accredited investor within the meaning of Regulation D and (Z) each such Affiliate agrees to be bound by the terms and conditions of this Agreement, and in particular, confirms to the Company that all of the representations set forth in Section 4 of this Agreement are true and correct as to such Affiliate as of the date of the transfer to such Affiliate. |
A-9
(ii) Prior to any proposed transfer pursuant to clause (B), (C), (D), (E) or (F) in Section 4(j)(i) above, such Purchaser shall give written notice to the Company of such Purchasers intention to effect such transfer. Each such notice shall describe the manner and circumstances of the proposed transfer in sufficient detail, and shall be accompanied by the applicable legal opinion, no action letter or seller and broker representation letters. | |
(iii) Notwithstanding the foregoing provisions of this Section 4(j), no registration statement, legal opinion or no action letter shall be necessary for a transfer of the Purchased Securities or the Warrant Shares (A) by a Purchaser that is a partnership to a partner of such partnership or a retired partner of such partnership who retires after the date of this Agreement, (B) by a Purchaser that is a limited liability company to a member of such limited liability company, (C) by a Purchaser that is a partnership or limited liability company to the estate of any partner, retired partner, or member thereof or (D) by any partner or member of a Purchaser that is a partnership or limited liability company by gift, will or intestate succession to such partner or members spouse or to the siblings, lineal descendants, ancestors of such partner or member or his or her spouse. |
(i) Such Purchaser agrees that, to the extent necessary, the certificates for the Purchased Shares and the Warrant Shares shall bear the following legend: |
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT) OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD OR TRANSFERRED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SECURITIES IS EFFECTIVE UNDER THE SECURITIES ACT OR (II) THE TRANSACTION IS EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT AND, IF THE COMPANY REQUESTS, AN OPINION SATISFACTORY TO THE COMPANY TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL. |
A-10
(ii) Such Purchaser agrees that the Purchased Warrants shall bear the following legend: |
THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT) OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD OR TRANSFERRED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SECURITIES IS EFFECTIVE UNDER THE SECURITIES ACT OR (II) THE TRANSACTION IS EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT AND, IF THE COMPANY REQUESTS, AN OPINION SATISFACTORY TO THE COMPANY TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL. |
A-11
(i) file in a timely manner a Form D relating to the sale of the Purchased Securities under this Agreement, pursuant to Regulation D; | |
(ii) prepare and file with the SEC as soon as practicable and in no event later than thirty (30) days following the Closing Date the (Required Filing Date), a registration statement on Form S-3 or such other form that is available to the Company under the Securities Act (the Registration Statement), to enable the resale of the Purchased Shares and the Warrant Shares (together with any shares of Common Stock issued as a dividend or other distribution with respect to, or in exchange for, or in replacement of, the Purchased Shares or the Warrant Shares, the Registrable Shares) by the Purchasers from time to time. The Company shall use its commercially reasonable efforts to cause the Registration Statement (x) to be declared effective as promptly as possible after filing, but in any event, no later than the 120th day following the Closing Date (the Required Effective Date), and (y) to remain continuously effective until the earlier of (1) the second anniversary of the effective date of the Registration Statement, (2) the date on which all Registrable Shares purchased by the Purchasers pursuant to this Agreement have been sold thereunder or (3) the date on which the Registrable Shares become eligible for resale pursuant to Rule 144(k) promulgated under the Securities Act (the Registration Period); provided, however, that if any Purchaser is an affiliate of the Company (as defined in Rule 144(a)(1) of the Securities Act) on the second anniversary of the effective date of the Registration Statement, the applicable time period for purposes of clause (1) above shall be the third anniversary of the effective date of the Registration Statement. If the Company receives notification from the SEC that the Registration Statement will receive no action or review from the SEC, then the Company will use its commercially reasonable efforts to cause the Registration Statement to become effective within five (5) Business Days after such SEC notification; | |
(iii) prepare and file with the SEC such amendments (including post-effective amendments) and supplements to the Registration Statement and the Prospectus (as defined below) used in connection therewith as may be necessary to keep the Registration Statement effective at all times until the end of the Registration Period; |
A-12
(iv) furnish to the Purchasers, with respect to the Registrable Shares registered under the Registration Statement, such reasonable number of copies of any prospectus in conformity with the requirements of the Securities Act and such other documents as the Purchasers may reasonably request in writing, in order to facilitate the public sale or other disposition of all or any of the Registrable Shares by the Purchasers; | |
(v) use its commercially reasonable efforts to file documents required of the Company for normal blue sky clearance in states specified in writing by the Purchasers; provided, however, that the Company shall not be required to qualify to do business or consent to service of process in any jurisdiction in which it is not now so qualified or has not so consented; | |
(vi) promptly notify the Purchasers in writing of the effectiveness of the Registration Statement on the same day the Registration Statement has been declared effective; | |
(vii) promptly notify the Purchasers in writing of the existence of any fact or the happening of any event, during the Registration Period (but not as to the substance of any such fact or event), that makes any statement of a material fact made in the Registration Statement, the Prospectus, any amendment or supplement thereto, or any document incorporated by reference therein untrue, or that requires the making of any additions to or changes in the Registration Statement or the Prospectus in order to make such statements not misleading; provided, however, that no notice by the Company shall be required pursuant to this subsection (vii) in the event that the Company either contemporaneously files a prospectus supplement to update the Prospectus or, if applicable, a Current Report on Form 8-K or other appropriate Exchange Act report that is incorporated by reference into the Registration Statement, which, in either case, contains the requisite information with respect to such material event that results in such Registration Statement no longer containing any such untrue or misleading statements; | |
(viii) furnish to each Purchaser upon written request, from the date of this Agreement until the end of the Registration Period, one copy of its periodic reports filed with the SEC pursuant to the Exchange Act and the rules and regulations promulgated thereunder; and | |
(ix) bear all expenses in connection with the procedures described in paragraphs (i) through (viii) of this Section 5(a) and the registration of the Registrable Shares pursuant to the Registration Statement, other than fees and expenses, if any, of legal counsel or other advisers to the Purchasers or underwriting discounts, brokerage fees and commissions incurred by the Purchasers, if any. |
(i) Delay in Filing or Effectiveness of Registration Statement. In the event that the Registration Statement is not (A) filed by the Required Filing Date or (B) declared effective by the Required Effective Date, the Company shall pay to each Purchaser (except for any Purchaser whose failure to provide information as required hereunder causes a delay in filing or obtaining effectiveness) liquidated damages (in addition to the rights and remedies available to each Purchaser under applicable law and this Agreement), at a rate equal to one percent (1%) per month (pro rata on a 30-day basis) of the total purchase price of the Purchased Securities purchased by such Purchaser pursuant to this Agreement for the period from and including the first day following the Required Filing Date or Required Effective Date, as the case may be, until, but excluding, the actual filing date or the date the SEC declares the Registration Statement effective, as the case may be. Such liquidated damages shall be payable in cash within ten (10) days of the end of each one (1) month anniversary of the Required Filing Date or Required Effective Date, as the case may be. |
A-13
(ii) Lapse in Effectiveness of Registration Statement. In the event that the Registration Statement is filed and declared effective but, during the Registration Period, the Registration Statement ceases to be effective or useable or the prospectus included in the Registration Statement (the Prospectus, as amended or supplemented by any prospectus supplement and by all other amendments thereto and all material incorporated by reference in such Prospectus) ceases to be usable, in either case, in connection with resales of Registrable Shares, without such lapse being cured within fifteen (15) Business Days (the Cure Period) by a post-effective amendment to the Registration Statement, a supplement to the Prospectus or a report filed with the SEC pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act that cures such lapse, then the Company shall pay to each Purchaser liquidated damages (in addition to the rights and remedies available to each Purchaser under applicable law and this Agreement), for the period from and including the first day following the expiration of the Cure Period until, but excluding, the earlier of (1) the date on which such failure is cured and (2) the date on which the Registration Period expires, at a rate equal to one percent (1%) per month (pro rata on a 30-day basis) of the total purchase price of the Purchased Securities purchased and still held by such Purchaser pursuant to this Agreement. Such liquidated damages shall be payable in cash within ten (10) days of the end of each one (1) month anniversary of the expiration of the Cure Period. |
(i) The Purchasers agree that they will not offer to sell or make any sale, assignment, pledge, hypothecation or other transfer with respect to the Registrable Shares that would constitute a sale within the meaning of the Securities Act except pursuant to either (1) the Registration Statement in the manner described in the Plan of Distribution therein, (2) Rule 144 of the Securities Act or (3) any other exemption from registration under the Securities Act, and that they will promptly notify the Company of any changes in the information set forth in the Registration Statement after it is prepared regarding the Purchaser or its plan of distribution to the extent required by applicable law. | |
(ii) In addition to any suspension rights under paragraph (iii) below, upon the happening of any pending corporate development, public filing with the SEC or similar event that, in the good faith judgment of the Board of Directors, renders it advisable to suspend the use of the Prospectus or upon the reasonable request by an underwriter in connection with an underwritten public offering of the Companys securities, the Company may suspend use of the Prospectus on written notice to each Purchaser (which notice will not disclose the content of any material non-public information and will indicate the date of the beginning and end of the intended period of suspension, if known), in which case each Purchaser shall discontinue any disposition of Registrable Shares covered by the Registration Statement or Prospectus until copies of a supplemented or amended Prospectus are distributed to the Purchasers or until the Purchasers are advised in writing by the Company that sales of Registrable Shares under the applicable Prospectus may be resumed and have received copies of any additional or supplemental filings that are incorporated or deemed incorporated by reference in any such Prospectus. Any such suspension under this paragraph (ii) shall not exceed sixty (60) days in any one hundred-eighty (180) day period or ninety (90) days in any twelve-month period. The suspension and notice thereof described in this Section 5(c)(ii) shall be held by each Purchaser in strictest confidence and shall not be disclosed by such Purchaser. | |
(iii) Subject to paragraph (iv) below, in the event of: (1) any request by the SEC or any other federal or state governmental authority during the Registration Period for amendments or supplements to a Registration Statement or related prospectus or for additional information; (2) the issuance by the SEC or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement or the initiation of any proceedings for that purpose; (3) the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Shares for sale in any jurisdiction or the initiation of any proceeding for such purpose; or (4) any event or circumstance which necessitates the making of any changes in the Registration Statement or Prospectus, or any document incorporated or deemed to be incorporated therein by reference, so that, in the case of the Registration Statement, it will not contain any untrue statement of a material fact or any omission to state a material fact required to be stated |
A-14
therein or necessary to make the statements therein not misleading, and that in the case of the Prospectus, it will not contain any untrue statement of a material fact or any omission to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, then the Company shall deliver a certificate in writing to the Purchasers (the Suspension Notice) to the effect of the foregoing (which notice will not disclose the content of any material non-public information and will indicate the date of the beginning and end of the intended period of suspension, if known), and, upon receipt of such Suspension Notice, the Purchasers will discontinue disposition of Registrable Shares covered by to the Registration Statement or Prospectus (a Suspension) until the Purchasers receipt of copies of a supplemented or amended Prospectus prepared and filed by the Company, or until the Purchasers are advised in writing by the Company that the current Prospectus may be used and have received copies of any additional or supplemental filings that are incorporated or deemed incorporated by reference in any such prospectus. In the event of any Suspension, the Company will use its commercially reasonable efforts to cause the use of the Prospectus so suspended to be resumed as soon as possible after delivery of a Suspension Notice to the Purchasers. The Suspension and Suspension Notice described in this Section 5(c)(iii) shall be held in strictest confidence by each Purchaser and shall not be disclosed by such Purchaser. | |
(iv) Provided that a Suspension is not then in effect, the Purchasers may sell Registrable Shares under the Registration Statement, provided that the selling Purchaser arranges for delivery of a current Prospectus to the transferee of such Registrable Shares to the extent such delivery is required by applicable law. | |
(v) In the event of a sale of Registrable Shares by a Purchaser, such Purchaser must also deliver to the Companys transfer agent, with a copy to the Company, a certificate of subsequent sale reasonably satisfactory to the Company, so that ownership of the Registrable Shares may be properly transferred. The Company will cooperate to facilitate the timely preparation and delivery of certificates (unless otherwise required by applicable law) representing Registrable Shares sold. |
(i) Indemnification by the Company. The Company agrees to indemnify and hold harmless each of the Purchasers, their respective officers, directors, agents and employees, and each person, if any, who controls any Purchaser within the meaning of the Securities Act, against any losses, claims, damages, liabilities or expenses, joint or several, to which such Purchasers, such officers, directors, agents or employees, or such controlling persons may become subject, under the Securities Act, the Exchange Act |
A-15
or any other federal or state statutory law or regulation, or at common law or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent of the Company, which consent shall not be unreasonably withheld), insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof as contemplated below) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the Registration Statement, the Prospectus, or any amendment or supplement to the Registration Statement or Prospectus, or arise out of or are based upon the omission or alleged omission to state in any of them a material fact required to be stated therein or necessary to make the statements in any of them, in light of the circumstances under which they were made, not misleading, and will reimburse each Purchaser, each of its respective directors, officers, agents and employees, and each such controlling person for any reasonable out-of-pocket legal and other expenses incurred by such Purchaser, such directors, officers, agents or employees, or such controlling persons in connection with investigating, defending, settling, compromising or paying any such loss, claim, damage, liability, expense or action; provided, however, that the Company will not be liable for any such case to the extent that any such loss, claim, damage, liability, expense or action arises out of or is based upon (1) an untrue statement or alleged untrue statement or omission or alleged omission in the Registration Statement, the Prospectus or any amendment to or supplement of the Registration Statement or the Prospectus made in reliance upon and in conformity with written information furnished to the Company by or on behalf of the Purchaser demanding such indemnification expressly for use in the Registration Statement or the Prospectus, (2) the failure of such Purchaser to comply with the covenants and agreements contained in this Agreement respecting resale of the Purchased Securities or the Warrant Shares or (3) any untrue statement or omission of a material fact required to make such statement not misleading in any Prospectus that is corrected in any subsequent Prospectus that was delivered to such Purchaser before the pertinent sale or sales by such Purchaser. | |
(ii) Indemnification by each Purchaser. Each Purchaser agrees, severally and not jointly, to indemnify and hold harmless the Company, each of the Companys directors, officers, agents and employees, and each person, if any, who controls the Company within the meaning of the Securities Act, against any losses, claims, damages, liabilities or expenses to which the Company, the Companys directors, officers, agents or employees, or any controlling persons may become subject, under the Securities Act, the Exchange Act, or any other federal or state statutory law or regulation, or at common law or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent of such Purchaser, which consent shall not be unreasonably withheld) insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof as contemplated below) arise out of or are based upon any untrue or alleged untrue statement of any material fact contained in the Registration Statement, the Prospectus, or any amendment or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement, the Prospectus, or any amendment or supplement thereto, in reliance upon and in conformity with written information furnished to the Company by or on behalf of such Purchaser expressly for use therein, and such Purchaser will reimburse the Company, each of its directors, officers, agents and employees, and any controlling persons for any reasonable legal and other expenses incurred by the Company, its directors, officers, agents or employees, or any controlling persons in connection with investigating, defending, settling, compromising or paying any such loss, claim, damage, liability, expense or action; provided, however, that such Purchaser shall not be liable for any such untrue or alleged untrue statement or omission or alleged omission with respect to which such Purchaser has delivered to the Company in writing a correction of such untrue or alleged untrue statement or omission or alleged omission, before the occurrence of the event from which such loss, claim, damage, liability or expense was incurred. Notwithstanding the provisions of this Section 5(e), such Purchaser shall not be liable for any indemnification obligation under this Agreement in excess of the aggregate amount of net proceeds received by such Purchaser from the sale of the Registrable Shares pursuant to the Registration Statement. |
A-16
(iii) Indemnification Procedure. |
(1) Promptly after receipt by an indemnified party under this Section 5(e) of notice of the threat or commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against an indemnifying party under this Section 5(e), promptly notify the indemnifying party in writing of the claim and provide to the indemnifying party copies of all written documents relating to such threatened or commenced action; but the omission so to notify the indemnifying party will not relieve it from any liability which it may have to any indemnified party for contribution or otherwise under the indemnity agreement contained in this Section 5(e) or otherwise, to the extent it is not prejudiced as a result of such failure. | |
(2) In case any such action is brought against any indemnified party and such indemnified party seeks or intends to seek indemnity from an indemnifying party, the indemnifying party will be entitled to participate in, and, to the extent that it may wish, jointly with all other indemnifying parties similarly notified, to assume the defense thereof with counsel reasonably satisfactory to such indemnified party; provided, however, that if the defendants in any such action include both the indemnified party and the indemnifying party and counsel to the indemnified party shall have reasonably concluded that there may be a conflict between the positions of the indemnifying party and the indemnified party in conducting the defense of any such action or that there may be legal defenses available to it or other indemnified parties that are different from or additional to those available to the indemnifying party, the indemnified party or parties shall have the right to select separate counsel to assume such legal defenses and to otherwise participate in the defense of such action on behalf of such indemnified party or parties. Upon receipt of notice from the indemnifying party to such indemnified party of its election so to assume the defense of such action and approval by the indemnified party of counsel, the indemnifying party will not be liable to such indemnified party under this Section 5(e) for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof unless: |
a) the indemnified party shall have employed such counsel in connection with the assumption of legal defenses in accordance with the proviso to the preceding sentence (it being understood, however, that the indemnifying party shall not be liable for the expenses of more than one separate counsel, reasonably approved by such indemnifying party, representing all of the indemnified parties who are parties to such action); or | |
b) the indemnifying party shall not have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified party within a reasonable time after notice of commencement of the action against the indemnified party, |
in each of which cases the reasonable out-of-pocket fees and expenses of counsel for the indemnified party shall be at the expense of the indemnifying party. |
(iv) Contribution. If the indemnification provided for in this Section 5(e) is required by its terms but is for any reason held to be unavailable to, or is otherwise insufficient to hold harmless, an indemnified party under this Section 5(e) with respect to any losses, claims, damages, liabilities or expenses referred to in this Agreement, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of any losses, claims, damages, liabilities or expenses referred to in this Agreement: |
(1) in such proportion as is appropriate to reflect the relative faults of the Company and the Purchasers in connection with the statements or omissions or inaccuracies in the representations and warranties in this Agreement that resulted in such losses, claims, damages, liabilities or expenses, as well as any other relevant equitable considerations, or | |
(2) if the allocation provided by clause (1) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative faults referred to in clause (1) above but also the relative benefits received by the Company and the Purchasers from the sale of the Purchased Securities. |
A-17
A-18
A-19
A-20
Zix Corporation | |
2711 N. Haskell Avenue | |
Suite 2300, LB36 | |
Dallas, Texas ###-###-#### | |
Attn: Ronald A. Woessner, General Counsel | |
Facsimile: 214 ###-###-#### |
Baker Botts L.L.P. | |
2001 Ross Avenue | |
Dallas, Texas 75201 | |
Attn: Sarah Rechter | |
Facsimile: 214 ###-###-#### |
A-21
A-22
ZIX CORPORATION |
By: | /s/ Brad Almond |
| |
Name: Brad Almond | |
Title: Chief Financial Officer |
A-23
Number of Purchased Shares Purchased: | 250,000 | |||||
Number of Purchased Warrants Purchased: | 82,500 | |||||
Total Number of Units Purchased: | 250,000 | |||||
Schottenfeld Qualified Associates, L.P. | ||||||
Purchaser Signature: | /s/ Richard Schottenfeld | |||||
Name: | Richard Schottenfeld | |||||
Title: | Managing Member | |||||
Number of Purchased Shares Purchased: | 100,000 | |||||
Number of Purchased Warrants Purchased: | 33,000 | |||||
Total Number of Units Purchased: | 100,000 | |||||
Cranshire Capital, L.P. | ||||||
Purchaser Signature: | /s/ Mitchell P. Kopin | |||||
Name: | Mitchell P. Kopin | |||||
Title: | President of Downshire Capital, Inc., | |||||
the General Partner of the Purchaser | ||||||
Number of Purchased Shares Purchased: | 80,000 | |||||
Number of Purchased Warrants Purchased: | 26,400 | |||||
Total Number of Units Purchased: | 80,000 | |||||
Nite Capital LP | ||||||
Purchaser Signature: | /s/ Keith A. Goodman | |||||
Name: | Keith A. Goodman | |||||
Title: | Manager of the General | |||||
Partner of the Purchaser | ||||||
A-24
Number of Purchased Shares Purchased: 100,000 Number of Purchased Warrants Purchased: 33,000 Total Number of Units Purchased: 100,000 Bluegrass Growth Fund, LP Purchaser Signature:
/s/ Brian Shatz Name: Brian Shatz Title: Managing Member Bluegrass Growth Fund, LLC Number of Purchased Shares Purchased: 80,000 Number of Purchased Warrants Purchased: 26,400 Total Number of Units Purchased: 80,000 Alpha Capital AG Purchaser Signature:
/s/ Konrad Ackermann Name: Konrad Ackermann Title: Director Number of Purchased Shares Purchased: 260,000 Number of Purchased Warrants Purchased: 85,800 Total Number of Units Purchased: 260,000 Gryphon Master Fund, L.P. Purchaser Signature:
/s/ E.B. Lyon IV Name: E.B. Lyon IV Title: Authorized Agent Number of Purchased Shares Purchased: 140,000 Number of Purchased Warrants Purchased: 46,200 Total Number of Units Purchased: 140,000 GSSF Master Fund, LP Purchaser Signature:
/s/ E.B. Lyon IV Name: E.B. Lyon IV Title: Authorized Agent
A-25
Number of Purchased Shares Purchased: 115,000 Number of Purchased Warrants Purchased: 37,950 Total Number of Units Purchased: 115,000 Precept Capital Master Fund, G.P. Purchaser By: its agent & attorney in fact, Precept Capital Management, LP By: its General Partner, Precept Management LLC Signature: /s/ D. Blair Baker Name: D. Blair Baker Title: President and CEO Number of Purchased Shares Purchased: 200,000 Number of Purchased Warrants Purchased: 66,000 Total Number of Units Purchased: 200,000 JMG Capital Partners, LP Purchaser Signature:
/s/ Jonathan Glaser Name: Jonathan Glaser Title: Member Manager of the GP Number of Purchased Shares Purchased: 200,000 Number of Purchased Warrants Purchased: 66,000 Total Number of Units Purchased: 200,000 JMG Triton Offshore Fund, Ltd. Purchaser Signature:
/s/ Jonathan Glaser Name: Jonathan Glaser Title: Member Manager of the Investment Manager
A-26
Number of Purchased Shares Purchased: 600,000 Number of Purchased Warrants Purchased: 198,000 Total Number of Units Purchased: 600,000 Heartland Group, Inc. solely on behalf of the Heartland Value Plus Fund Purchaser Signature:
/s/ Nicole J. Best Name: Nicole J. Best Title: Treasurer and Principal Accounting Officer Number of Purchased Shares Purchased: 100,000 Number of Purchased Warrants Purchased: 33,000 Total Number of Units Purchased: 100,000 Diamond Opportunity Fund, LLC Purchaser Signature:
/s/ Rob Rubin Name: Rob Rubin Title: Principal Number of Purchased Shares Purchased: 2,000,000 Number of Purchased Warrants Purchased: 660,000 Total Number of Units Purchased: 2,000,000 Andrew J. Hoff Purchaser Signature:
/s/ Andrew J. Hoff Name: Andrew J. Hoff Title: N/A Number of Purchased Shares Purchased: 800,000 Number of Purchased Warrants Purchased: 264,000 Total Number of Units Purchased: 800,000 George W. Haywood Purchaser Signature:
/s/ George W. Haywood Name: George W. Haywood Title: N/A
A-27
Number of Purchased Shares Purchased: 400,000 Number of Purchased Warrants Purchased: 132,000 Total Number of Units Purchased: 400,000 Superius Securities GP Profit Sharing Plan Purchaser Signature:
/s/ James Hudgins Name: James Hudgins Title: Trustee Number of Purchased Shares Purchased: 22,000 Number of Purchased Warrants Purchased: 7,260 Total Number of Units Purchased: 22,000 Arthur R. Puglia Purchaser Signature:
/s/ Arthur R. Puglia Name: Arthur R. Puglia Title: N/A Number of Purchased Shares Purchased: 20,000 Number of Purchased Warrants Purchased: 6,600 Total Number of Units Purchased: 20,000 Manickam Ganesh Purchaser Signature:
/s/ Manickam Ganesh Name: Manickam Ganesh Title: N/A Number of Purchased Shares Purchased: 20,000 Number of Purchased Warrants Purchased: 6,600 Total Number of Units Purchased: 20,000 William McCauley Purchaser Signature:
/s/ William McCauley Name: William McCauley Title: N/A
A-28
Number of Purchased Shares Purchased: 40,000 Number of Purchased Warrants Purchased: 13,200 Total Number of Units Purchased: 40,000 Alapatt P. Thomas, MD Purchaser Signature:
/s/ Alapatt P. Thomas, MD Name: Alapatt P. Thomas, MD Title: N/A Number of Purchased Shares Purchased: 22,600 Number of Purchased Warrants Purchased: 7,458 Total Number of Units Purchased: 22,600 Hersey Norris Purchaser Signature:
/s/ Hersey Norris Name: Hersey Norris Title: N/A Number of Purchased Shares Purchased: 37,400 Number of Purchased Warrants Purchased: 12,342 Total Number of Units Purchased: 37,400 Howard Raphaelson Purchaser Signature:
/s/ Howard Raphaelson Name: Howard Raphaelson Title: N/A Number of Purchased Shares Purchased: 20,000 Number of Purchased Warrants Purchased 6,600 Total Number of Units Purchased: 20,000 Ronald S. Carvalho Purchaser Signature:
/s/ Ronald S. Carvalho Name: Ronald S. Carvalho Title: N/A
A-29
Number of Purchased Shares Purchased: 30,000 Number of Purchased Warrants Purchased: 9,900 Total Number of Units Purchased: 30,000 William Leggio Purchaser Signature:
/s/ William Leggio Name: William Leggio Title: N/A Number of Purchased Shares Purchased: 139,600 Number of Purchased Warrants Purchased: 46,068 Total Number of Units Purchased: 139,600 Capra Global Managed Assets, Ltd. Purchaser Signature:
/s/ James R. Capra Name: James R. Capra Title: Director Number of Purchased Shares Purchased: 60,400 Number of Purchased Warrants Purchased: 19,932 Total Number of Units Purchased: 60,400 CGMA Special Accounts, LLC Purchaser Signature:
/s/ James R. Capra Name: James R. Capra Title: Director Number of Purchased Shares Purchased: 200,000 Number of Purchased Warrants Purchased: 66,000 Total Number of Units Purchased: 200,000 Antonio R. Sanchez, Jr. Purchaser Signature:
/s/ Antonio R. Sanchez, Jr. Name: Antonio R. Sanchez, Jr. Title: N/A
A-30
Number of Purchased Shares Purchased: 200,000 Number of Purchased Warrants Purchased: 66,000 Total Number of Units Purchased: 200,000 Con Egan Purchaser Signature:
/s/ Con Egan Name: Con Egan Title: N/A Number of Purchased Shares Purchased: 150,000 Number of Purchased Warrants Purchased: 49,500 Total Number of Units Purchased: 150,000 Conor ODriscoll Purchaser Signature:
/s/ Conor ODriscoll Name: Conor ODriscoll Title: N/A Number of Purchased Shares Purchased: 120,000 Number of Purchased Warrants Purchased: 39,600 Total Number of Units Purchased: 120,000 Fulvio Dobrich Purchaser Signature:
/s/ Fulvio Dobrich Name: Fulvio Dobrich Title: N/A Number of Purchased Shares Purchased: 100,000 Number of Purchased Warrants Purchased: 33,000 Total Number of Units Purchased: 100,000 John M. Craig Purchaser Signature:
John M. Craig Name: John M. Craig Title: N/A
A-31
Number of Purchased Shares Purchased: 60,000 Number of Purchased Warrants Purchased: 19,800 Total Number of Units Purchased: 60,000 Anthony J. Pannella Purchaser Signature:
/s/ Anthony J. Pannella Name: Anthony J. Pannella Title: N/A Number of Purchased Shares Purchased: 60,000 Number of Purchased Warrants Purchased: 19,800 Total Number of Units Purchased: 60,000 Stephen D. Baska Purchaser Signature:
/s/ Stephen D. Baska Name: Stephen D. Baska Title: N/A Number of Purchased Shares Purchased: 33,446 Number of Purchased Warrants Purchased: 11,037 Total Number of Units Purchased: 33,446 Antonio R. Sanchez, III Purchaser Signature:
/s/ Antonio R. Sanchez, III Name: Antonio R. Sanchez, III Title: N/A Number of Purchased Shares Purchased: 40,000 Number of Purchased Warrants Purchased: 13,200 Total Number of Units Purchased: 40,000 Robert P. Janke and Debbie Hansman Purchaser Signature:
/s/ Robert P. Janke /s/ Debbie Hansman Name: Robert P. Janke Debbie Hansman Title: N/A
A-32
Number of Purchased Shares Purchased: 16,724 Number of Purchased Warrants Purchased: 5,519 Total Number of Units Purchased: 16,724 Richard D. Spurr Purchaser Signature:
/s/ Richard D. Spurr Name: Richard D. Spurr Title: N/A Number of Purchased Shares Purchased: 3,346 Number of Purchased Warrants Purchased: 1,104 Total Number of Units Purchased: 3,346 Bradley C. Almond Purchaser Signature:
/s/ Bradley C. Almond Name: Bradley C. Almond Title: N/A Number of Purchased Shares Purchased: 3,346 Number of Purchased Warrants Purchased: 1,104 Total Number of Units Purchased: 3,346 Charles N. Kahn III Purchaser Signature:
/s/ Charles N. Kahn III Name: Charles N. Kahn III Title: N/A Number of Purchased Shares Purchased: 100,000 Number of Purchased Warrants Purchased: 33,000 Total Number of Units Purchased: 100,000 Anthony V. Milone Purchaser Signature:
/s/ Anthony V. Milone Name: Anthony V. Milone Title: N/A
A-33
Number of Purchased Shares Purchased: 50,000 Number of Purchased Warrants Purchased: 16,500 Total Number of Units Purchased: 50,000 Sapphire Capital Partners, L.P. Purchaser Signature:
/s/ Matthew Buten Name: Matthew Buten Title: Managing Member Number of Purchased Shares Purchased: 80,000 Number of Purchased Warrants Purchased: 26,400 Total Number of Units Purchased: 80,000 Reuben Taub Purchaser Signature:
/s/ Reuben Taub Name: Reuben Taub Title: N/A Number of Purchased Shares Purchased: 400,000 Number of Purchased Warrants Purchased: 132,000 Total Number of Units Purchased: 400,000 C.E. Unterberg, Towbin Capital Partners I, L.P. Purchaser Signature:
/s/ Andrew Arno Name: Andrew Arno Title: Managing Member of the GP Number of Purchased Shares Purchased: 23,920 Number of Purchased Warrants Purchased: 7,894 Total Number of Units Purchased: 23,920 SRB Greenway Capital, L.P. Purchaser By:
SRB Management, L.P., General Partner By: BC Advisors, L.L.C., General Partner Signature: /s/ Stephen R. Becker Name: Stephen R. Becker Title: Member
A-34
Number of Purchased Shares Purchased: 162,680 Number of Purchased Warrants Purchased: 53,684 Total Number of Units Purchased: 162,680 SRB Greenway Capital (QP), L.P. Purchaser By: SRB Management, L.P., General Partner By: BC Advisors, L.L.C., General Partner Signature: /s/ Stephen R. Becker Name: Stephen R. Becker Title: Member Number of Purchased Shares Purchased: 13,400 Number of Purchased Warrants Purchased: 4,422 Total Number of Units Purchased: 13,400 SRB Greenway Offshore Operating Fund, L.P. Purchaser By: SRB Management, L.P., General Partner By: BC Advisors, L.L.C., General Partner Signature: /s/ Steve Becker Name: Steve Becker Title: Member Number of Purchased Shares Purchased: 200,000 Number of Purchased Warrants Purchased: 66,000 Total Number of Units Purchased: 200,000 Shea Ventures, LLC Purchaser Signature:
/s/ John C. Morrissey Name: John C. Morrissey Title: Vice President
A-35
Number of Purchased Shares Purchased: 2,250,000 Number of Purchased Warrants Purchased: 742,500 Total Number of Units Purchased: 2,250,000 Amulet Limited Purchaser By: Amaranth Advisors L.L.C., its Trading Advisor Signature: /s/ Karl J. Wachter Name: Karl J. Wachter Title: Authorized Signatory Number of Purchased Shares Purchased: 400,000 Number of Purchased Warrants Purchased: 132,000 Total Number of Units Purchased: 400,000 Omicron Master Trust Purchaser Signature:
/s/ Oliver Morali Name: Oliver Morali Title: Managing Partner, Investment Advisor
A-36
Total Number of | Number of | Number of | Total Number of | Number of | Number of | |||||||||||||||||||||||||||||||
Name and Address | Purchased Shares | Firm Shares | Excess Shares | Purchased Warrants | Firm Warrants | Excess Warrants | Firm Funds | Excess Funds | Total Purchase Price | |||||||||||||||||||||||||||
Schottenfeld Qualified Associates, L.P. 800 Third Avenue 10th Floor New York, New York 10022 Tel: 212 ###-###-#### Fax: 212 ###-###-#### Attn: Richard Schottenfeld | 250,000 | 150,000 | 100,000 | 82,500 | 49,500 | 33,000 | 375,000.00 | 250,000.00 | 625,000.00 | |||||||||||||||||||||||||||
Cranshire Capital, L.P. 666 Dundee Road, Suite 1901 Northbrook, IL 60062 Tel: 847 ###-###-#### Fax: 847 ###-###-#### Attn: Mitchell Kopin | 100,000 | 60,000 | 40,000 | 33,000 | 19,800 | 13,200 | 150,000.00 | 100,000.00 | 250,000.00 | |||||||||||||||||||||||||||
Nite Capital LP 100 East Cook Avenue Suite 201 Libertyville, IL 60048 Tel: 847 ###-###-#### Fax: 847 ###-###-#### Attn: Keith A. Goodman | 80,000 | 48,000 | 32,000 | 26,400 | 15,840 | 10,560 | 120,000.00 | 80,000.00 | 200,000.00 |
Total Number of | Number of | Number of | Total Number of | Number of | Number of | |||||||||||||||||||||||||||||||
Name and Address | Purchased Shares | Firm Shares | Excess Shares | Purchased Warrants | Firm Warrants | Excess Warrants | Firm Funds | Excess Funds | Total Purchase Price | |||||||||||||||||||||||||||
Bluegrass Growth Fund, LP 122 E. 42nd Street Suite 2606 New York, NY 10168 Tel: 212 ###-###-#### Fax: 212 ###-###-#### Attn: Brian Shatz | 100,000 | 60,000 | 40,000 | 33,000 | 19,800 | 13,200 | 150,000.00 | 100,000.00 | 250,000.00 | |||||||||||||||||||||||||||
Alpha Capital AG c/o LH Financial 160 Central Park South Suite 2701 New York, NY 10019 Tel: 212 ###-###-#### Fax: 212 ###-###-#### Attn: Joseph Hammer | 80,000 | 48,000 | 32,000 | 26,400 | 15,840 | 10,560 | 120,000.00 | 80,000.00 | 200,000.00 | |||||||||||||||||||||||||||
Gryphon Master Fund, L.P. 100 Crescent Court Suite 490 Dallas, Texas 75201 Tel: 214 ###-###-#### Fax: 214 ###-###-#### Attn: Mr. Tim Stobaugh | 260,000 | 156,000 | 104,000 | 85,800 | 51,480 | 34,320 | 390,000.00 | 260,000.00 | 650,000.00 | |||||||||||||||||||||||||||
GSSF Master Fund, LP 100 Crescent Court Suite 490 Dallas, Texas 75201 Tel: 214 ###-###-#### Fax: 214 ###-###-#### Attn: Mr. Tim Stobaugh | 140,000 | 84,000 | 56,000 | 46,200 | 27,720 | 18,480 | 210,000.00 | 140,000.00 | 350,000.00 |
Total Number of | Number of | Number of | Total Number of | Number of | Number of | |||||||||||||||||||||||||||||||
Name and Address | Purchased Shares | Firm Shares | Excess Shares | Purchased Warrants | Firm Warrants | Excess Warrants | Firm Funds | Excess Funds | Total Purchase Price | |||||||||||||||||||||||||||
Precept Capital Master Fund, G.P. 100 Crescent Court Suite 850 Dallas, Texas 75201 Tel: 214 ###-###-#### Fax: 214 ###-###-#### Attn: John Bateman | 115,000 | 69,000 | 46,000 | 37,950 | 22,770 | 15,180 | 172,500.00 | 115,000.00 | 287,500.00 | |||||||||||||||||||||||||||
JMG Capital Partners, LP 11601 Wilshire Blvd. Suite 2180 Los Angeles, CA 90025 Tel: 310 ###-###-#### Fax: 310.61.2890 Attn: Mr. Jonathan Glaser | 200,000 | 120,000 | 80,000 | 66,000 | 39,600 | 26,400 | 300,000.00 | 200,000.00 | 500,000.00 | |||||||||||||||||||||||||||
JMG Triton Offshore Fund, Ltd. 11601 Wilshire Blvd. Suite 2180 Los Angeles, CA 90025 Tel: 310 ###-###-#### Fax: 310.61.2890 Attn: Mr. Jonathan Glaser | 200,000 | 120,000 | 80,000 | 66,000 | 39,600 | 26,400 | 300,000.00 | 200,000.00 | 500,000.00 | |||||||||||||||||||||||||||
Heartland Value Plus Fund c/o Brown Brothers Harriman & Co. c/o Heartland Group, Inc. 789 N. Water St., Suite 500 Milwaukee, WI 53202 Tel: 414 ###-###-#### Fax: 414 ###-###-#### Attn: Nicole J. Best | 600,000 | 360,000 | 240,000 | 198,000 | 118,800 | 79,200 | 900,000.00 | 600,000.00 | 1,500,000.00 |
Total Number of | Number of | Number of | Total Number of | Number of | Number of | |||||||||||||||||||||||||||||||
Name and Address | Purchased Shares | Firm Shares | Excess Shares | Purchased Warrants | Firm Warrants | Excess Warrants | Firm Funds | Excess Funds | Total Purchase Price | |||||||||||||||||||||||||||
Diamond Opportunity Fund, LLC 500 Skokie Blvd. Suite 310 Northbrook, IL 60062 Tel: 847 ###-###-#### Fax: 847 ###-###-#### Attn: Richard Marks | 100,000 | 60,000 | 40,000 | 33,000 | 19,800 | 13,200 | 150,000.00 | 100,000.00 | 250,000.00 | |||||||||||||||||||||||||||
Andrew J. Hoff 731 N. Jackson Street Suite 812 Milwaukee, WI 53202 Tel: 414 ###-###-#### Fax: 414 ###-###-#### | 2,000,000 | 1,200,000 | 800,000 | 660,000 | 396,000 | 264,000 | 3,000,000.00 | 2,000,000.00 | 5,000,000.00 | |||||||||||||||||||||||||||
George W. Haywood 3023 Q. Street, N.W. Washington, D.C. 20007 Tel: 917 ###-###-#### Fax: 516 ###-###-#### (Attn: Gary Moomjian) | 800,000 | 480,000 | 320,000 | 264,000 | 158,400 | 105,600 | 1,200,000.00 | 800,000.00 | 2,000,000.00 | |||||||||||||||||||||||||||
Superius Securities GP Profit Sharing Plan 94 Grand Avenue Englewood, NJ 07631 Tel: 201 ###-###-#### Fax: 201 ###-###-#### Attn: Mr. James Hudgins | 400,000 | 240,000 | 160,000 | 132,000 | 79,200 | 52,800 | 600,000.00 | 400,000.00 | 1,000,000.00 | |||||||||||||||||||||||||||
Arthur R. Puglia 23499 Columbus Rd. Columbus, NJ 08022 Tel: 609 ###-###-#### Fax: 609 ###-###-#### | 22,000 | 13,200 | 8,800 | 7,260 (4,400 / 2,860)* | 4,356 (2,640 / 1,716)* | 2,904 (1,760 / 1,144)* | 33,000.00 | 22,000.00 | 55,000.00 |
Total Number of | Number of | Number of | Total Number of | Number of | Number of | |||||||||||||||||||||||||||||||
Name and Address | Purchased Shares | Firm Shares | Excess Shares | Purchased Warrants | Firm Warrants | Excess Warrants | Firm Funds | Excess Funds | Total Purchase Price | |||||||||||||||||||||||||||
Manickam Ganesh 5 Eccleston Court Montville, NJ 07045 Tel: 973 ###-###-#### Fax: 973 ###-###-#### | 20,000 | 12,000 | 8,000 | 6,600 (4,000 / 2,600)* | 3,960 (2,400 / 1,560)* | 2,640 (1,600 / 1,040)* | 30,000.00 | 20,000.00 | 55,000.00 | |||||||||||||||||||||||||||
William McCauley 492 Ackerson Avenue Wyckoff, NJ 07481 Tel: 201 ###-###-#### | 20,000 | 12,000 | 8,000 | 6,600 (4,000 / 2,600)* | 3,960 (2,400 / 1,560)* | 2,640 (1,600 / 1,040)* | 30,000.00 | 20,000.00 | 55,000.00 | |||||||||||||||||||||||||||
Alapatt P. Thomas, MD 9 Manor Drive Warren, NJ 07059 Tel: 973 ###-###-#### Fax: 973 ###-###-#### | 40,000 | 24,000 | 16,000 | 13,200 (8,000 / 5,200)* | 7,920 (4,800 / 3,120)* | 5,280 (3,200 / 2,080)* | 60,000.00 | 40,000.00 | 100,000.00 | |||||||||||||||||||||||||||
Hersey Norris 8553 Caratoke Hwy, US Hwy 158 Harbinger, NC 27941 Tel: 252 ###-###-#### Fax: 252 ###-###-#### | 22,600 | 13,560 | 9,040 | 7,458 (4,458 / 3,000)* | 4,475 (2,712 / 1,763)* | 2,983 (1,746 / 1,237)* | 33,900.00 | 22,600.00 | 56,500.00 | |||||||||||||||||||||||||||
Howard Raphaelson 10 Chauncey Place Woodbury, NY 11797 Tel: 212 ###-###-#### Fax: 212 ###-###-#### | 37,400 | 22,440 | 14,960 | 12,342 (7,342 / 5,000)* | 7,405 (4,488 / 2,917)* | 4,937 (2,854 / 2,083)* | 56,100.00 | 37,400.00 | 93,500.00 |
Total Number of | Number of | Number of | Total Number of | Number of | Number of | |||||||||||||||||||||||||||||||
Name and Address | Purchased Shares | Firm Shares | Excess Shares | Purchased Warrants | Firm Warrants | Excess Warrants | Firm Funds | Excess Funds | Total Purchase Price | |||||||||||||||||||||||||||
Ronald S. Carvalho 107 Osborne Place Cranford, NJ 07016 Tel: 908 ###-###-#### Fax: 908 ###-###-#### | 20,000 | 12,000 | 8,000 | 6,600 (4,000 / 2,600)* | 3,960 (2,400 / 1,560)* | 2,640 (1,600 / 1,040)* | 30,000.00 | 20,000.00 | 55,000.00 | |||||||||||||||||||||||||||
William R. Leggio 2 Charlton Street Apt. 11K New York, NY 10014 Tel: 212 ###-###-#### Fax: 212 ###-###-#### | 30,000 | 18,000 | 12,000 | 9,900 (6,000 / 3,900)* | 5,940 (3,600 / 2,340)* | 3,960 (2,400 / 1,560)* | 45,000.00 | 30,000.00 | 75,000.00 | |||||||||||||||||||||||||||
Capra Global Managed Assets, Ltd. c/o Walkers SPV Limited P.O. Box 908GT, Walker House Mary Street, Georgetown Grand Cayman, Cayman Islands Tel: 914 ###-###-#### Fax: 914 ###-###-#### Attn: Mr. John Briggs | 139,600 | 83,760 | 55,840 | 46,068 | 27,641 | 18,427 | 209,400.00 | 139,600.00 | 349,000.00 | |||||||||||||||||||||||||||
CGMA Special Accounts, LLC c/o Walkers SPV Limited P.O. Box 908GT, Walker House Mary Street, Georgetown Grand Cayman, Cayman Islands Tel: 914 ###-###-#### Fax: 914 ###-###-#### Attn: Mr. John Briggs | 60,400 | 36,240 | 24,160 | 19,932 | 11,959 | 7,973 | 90,600.00 | 60,400.00 | 151,000.00 |
Total Number of | Number of | Number of | Total Number of | Number of | Number of | |||||||||||||||||||||||||||||||
Name and Address | Purchased Shares | Firm Shares | Excess Shares | Purchased Warrants | Firm Warrants | Excess Warrants | Firm Funds | Excess Funds | Total Purchase Price | |||||||||||||||||||||||||||
Antonio R. Sanchez, Jr. 1920 Sandman Street Laredo, Texas 78041 Tel: 956 ###-###-#### Fax: 956 ###-###-#### | 200,000 | 120,000 | 80,000 | 66,000 | 39,600 | 26,400 | 300,000.00 | 200,000.00 | 500,000.00 | |||||||||||||||||||||||||||
Con Egan 225 East 70th Penthouse B New York, NY 10021 Tel: 212 ###-###-#### Fax: 212 ###-###-#### | 200,000 | 120,000 | 80,000 | 66,000 | 39,600 | 26,400 | 300,000.00 | 200,000.00 | 500,000.00 | |||||||||||||||||||||||||||
Conor ODriscoll 355 Locust Avenue Rye, NY 10580 Tel: 916 ###-###-#### Fax: 212 ###-###-#### | 150,000 | 90,000 | 60,000 | 49,500 | 29,700 | 19,800 | 225,000.00 | 150,000.00 | 375,000.00 | |||||||||||||||||||||||||||
Fulvio Dobrich c/o Galileo Asset Management 570 Lexington Avenue 24th Floor New York, NY 10022 Tel: 212 ###-###-#### Fax: 212 ###-###-#### | 120,000 | 72,000 | 48,000 | 39,600 | 23,760 | 15,840 | 180,000.00 | 120,000.00 | 300,000.00 | |||||||||||||||||||||||||||
John M. Craig 46 Cheese Spring Road Wilton, CT 06897 Tel: 203 ###-###-#### Fax: 203 ###-###-#### | 100,000 | 60,000 | 40,000 | 33,000 | 19,800 | 13,200 | 150,000.00 | 100,000.00 | 250,000.00 |
Total Number of | Number of | Number of | Total Number of | Number of | Number of | |||||||||||||||||||||||||||||||
Name and Address | Purchased Shares | Firm Shares | Excess Shares | Purchased Warrants | Firm Warrants | Excess Warrants | Firm Funds | Excess Funds | Total Purchase Price | |||||||||||||||||||||||||||
Anthony J. Pannella Wilentz, Goldman & Spitzer PA 90 Woodbridge Center Drive Woodbridge, NJ 07095 Tel: 732 ###-###-#### Fax: 732 ###-###-#### | 60,000 | 36,000 | 24,000 | 19,800 | 11,880 | 7,920 | 90,000.00 | 60,000.00 | 150,000.00 | |||||||||||||||||||||||||||
Stephen D. Baksa 2 Woods Lane Chatham, NJ 07928 Tel: 973 ###-###-#### | 60,000 | 36,000 | 24,000 | 19,800 | 11,880 | 7,920 | 90,000.00 | 60,000.00 | 150,000.00 | |||||||||||||||||||||||||||
Antonio R. Sanchez, III 1111 Bagby Suite 1600 Houston, Texas 77002 Tel: 713 ###-###-#### Fax: 713 ###-###-#### | 33,446 | 20,068 | 13,378 | 11,037 | 6,623 | 4,414 | 60,003.32 | 40,000.22 | 100,003.54 | |||||||||||||||||||||||||||
Robert P. Janke and Debbie Hansman 121 Highland Blvd. Bozeman, MT 59715 Tel: 406 ###-###-#### Attn: Mr. Robert Janke | 40,000 | 24,000 | 16,000 | 13,200 | 7,920 | 5,280 | 60,000.00 | 40,000.00 | 100,000.00 | |||||||||||||||||||||||||||
Richard D. Spurr 2711 North Haskell Suite 2200, LB 36 Dallas, Texas 75204 Tel: 214 ###-###-#### Fax: 214 ###-###-#### | 16,724 | 10,034 | 6,690 | 5,519 | 3,312 | 2,207 | 30,001.66 | 20,003.10 | 50,004.76 |
Total Number of | Number of | Number of | Total Number of | Number of | Number of | |||||||||||||||||||||||||||||||
Name and Address | Purchased Shares | Firm Shares | Excess Shares | Purchased Warrants | Firm Warrants | Excess Warrants | Firm Funds | Excess Funds | Total Purchase Price | |||||||||||||||||||||||||||
Bradley Christian Almond 1541 El Campo Dallas, Texas 75218 Tel: 214 ###-###-#### | 3,346 | 2,008 | 1,338 | 1,104 | 663 | 441 | 6,003.92 | 4,000.62 | 10,004.54 | |||||||||||||||||||||||||||
Charles N. Kahn, III 4545 Glebe Road Arlington, VA 22207 Tel: 202 ###-###-#### Fax: 202 ###-###-#### | 3,346 | 2,008 | 1,338 | 1,104 | 663 | 441 | 6,003.92 | 4,000.62 | 10,004.54 | |||||||||||||||||||||||||||
Anthony V. Milone 1 Hillview Court Armonk, NY 10504 or c/o HAN 1305 Maroneck Avenue White Plains, NY 10605 Tel: 914 ###-###-#### Fax: 914 ###-###-#### | 100,000 | 60,000 | 40,000 | 33,000 | 19,800 | 13,200 | 150,000.00 | 100,000.00 | 250,000.00 | |||||||||||||||||||||||||||
Sapphire Capital Partners, L.P. 527 Madison Avenue 7th Floor New York, NY 10013 Tel: 212 ###-###-#### Fax: 212 ###-###-#### Attn: Mr. Matthew Buton | 50,000 | 30,000 | 20,000 | 16,500 | 9,900 | 6,600 | 75,000.00 | 50,000.00 | 125,000.00 |
Total Number of | Number of | Number of | Total Number of | Number of | Number of | |||||||||||||||||||||||||||||||
Name and Address | Purchased Shares | Firm Shares | Excess Shares | Purchased Warrants | Firm Warrants | Excess Warrants | Firm Funds | Excess Funds | Total Purchase Price | |||||||||||||||||||||||||||
Reuben Taub 607 West End Avenue Apartment 4A New York, NY 10024 Tel: 917 ###-###-#### Fax: 212 ###-###-#### | 80,000 | 48,000 | 32,000 | 26,400 | 15,840 | 10,560 | 120,000.00 | 80,000.00 | 200,000.00 | |||||||||||||||||||||||||||
C.E. Unterberg, Towbin Capital Partners I, L.P. c/o C.E. Unterberg, Towbin 350 Madison Avenue New York, NY 10017 Tel: 212 ###-###-#### Fax: 212 ###-###-#### Attn: Andrew Arno | 400,000 | 240,000 | 160,000 | 132,000 | 79,200 | 52,800 | 600,000.00 | 400,000.00 | 1,000,000.00 | |||||||||||||||||||||||||||
SRB Greenway Capital, L.P. 300 Crescent Court Suite 1111 Dallas, Texas 75201 Tel: 214 ###-###-#### Fax: 214 ###-###-#### Attn: Joe Worsham | 23,920 | 14,352 | 9,568 | 7,894 | 4,736 | 3,158 | 35,880.00 | 23,920.00 | 59,800.00 | |||||||||||||||||||||||||||
SRB Greenway Capital (QP), L.P. 300 Crescent Court Suite 1111 Dallas, Texas 75201 Tel: 214 ###-###-#### Fax: 214 ###-###-#### Attn: Joe Worsham | 162,680 | 97,608 | 65,072 | 53,684 | 32,211 | 21,473 | 244,020.00 | 162,680.00 | 406,700.00 |
Total Number of | Number of | Number of | Total Number of | Number of | Number of | |||||||||||||||||||||||||||||||
Name and Address | Purchased Shares | Firm Shares | Excess Shares | Purchased Warrants | Firm Warrants | Excess Warrants | Firm Funds | Excess Funds | Total Purchase Price | |||||||||||||||||||||||||||
SRB Greenway Offshore Operating Fund, L.P. 300 Crescent Court Suite 1111 Dallas, Texas 75201 Tel: 214 ###-###-#### Fax: 214 ###-###-#### Attn: Joe Worsham | 13,400 | 8,040 | 5,360 | 4,422 | 2,653 | 1,769 | 20,100.00 | 13,400.00 | 33,500.00 | |||||||||||||||||||||||||||
Shea Ventures, LLC 655 Brea Canyon Road Walnut, CA 91789 Tel: 909 ###-###-#### Fax: 909 ###-###-#### Attn: Mr. Edmund H. Shea, Jr. | 200,000 | 120,000 | 80,000 | 66,000 | 39,600 | 26,400 | 300,000.00 | 200,000.00 | 500,000.00 | |||||||||||||||||||||||||||
Amulet Limited c/o Dundee Leeds Management Services (Cayman) Ltd. 28N. Church Street, Waterfront Centre, George Town, Grand Cayman, Cayman Islands, British West Indies with copies to: c/o Amaranth Advisors L.L.C. One American Lane Greenwich, CT 06831 Tel: 203 ###-###-#### Fax: 203 ###-###-#### Attn: General Counsel | 2,250,000 | 1,350,000 | 900,000 | 742,500 | 445,500 | 297,000 | 3,375,000.00 | 2,250,000.00 | 5,625,000.00 |
Total Number of | Number of | Number of | Total Number of | Number of | Number of | |||||||||||||||||||||||||||||||
Name and Address | Purchased Shares | Firm Shares | Excess Shares | Purchased Warrants | Firm Warrants | Excess Warrants | Firm Funds | Excess Funds | Total Purchase Price | |||||||||||||||||||||||||||
Omicron Master Trust c/o Omicron Capital, L.P. 650 Fifth Avenue 24th Floor New York, NY 10019 Tel: 212 ###-###-#### Fax: 212 ###-###-#### Attn: Brian Daly | 400,000 | 240,000 | 160,000 | 132,000 | 79,200 | 52,800 | 600,000.00 | 400,000.00 | 1,000,000.00 | |||||||||||||||||||||||||||
Total: | 10,503,862 | 6,302,318 | 4,201,544 | 3,466,274 | 2,079,767 | 1,386,507 | 15,772,512.82 | 10,515,004.56 | 26,287,517.38 |
Natural Person(s) | Relationship to Purchaser | |
Registered Broker-Dealer | Relationship to Purchaser | |
Name: |
State (or Country) of formation or incorporation: |
Contact Person: |
Telephone Number: |
Facsimile Number: |
Email Address: |
Type of Entity (corporation, partnership, trust, etc.): |
Social Security or Taxpayer or Employer Identification Number: |
o | other Please describe: |
Executed at , on , 2005. | ||
Name of Entity: | ||
By: | ||||
(Signature) | ||||
(Name and title of signatory) |
Capitalization
Governmental Consents
Non-Contravention
Litigation
Transactions with Officers and Directors
Registration Rights Agreements
Title to Property and Assets
filed on October 21, 2005.